IP Library Assignment 016795/0333
Patent Assignment
Reel/Frame 016795/0333

Assignment of Assignor's Interest

Recorded: 2005-11-17 Pages: 11
Assignors
SHENK, DALE B.
Executed: 2005-11-09
BUTTINI, MANUEL J.
Executed: 2005-11-03
CHILCOTE, TAMIE J.
Executed: 2005-11-10
GAMES, KATE DORA
Executed: 2005-10-14
MASLIAH, ELIEZER
Executed: 2005-11-07
ROCKENSTEIN, EDWARD M.
Executed: 2005-11-07
Assignees
ELAN PHARMACEUTICALS, INC.
800 GATEWAY BLVD., SO. SAN FRANCISCO, CALIFORNIA, 94080
REGENTS OF THE UNIVERSITY OF CALIFORNIA
1111 FRANKLIN STREET, 5TH FLOOR, OAKLAND, CALIFORNIA, 94607
Covered Property (1)
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
Patent: 8,506,959 →
Application: 11/185,907 →
Publication: US 2006/0058233
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Assignors Previously Recorded on Reel 016795 Frame 0333. Assignor(S) Hereby Confirms the Assignment of Assignors Interest. Aug 10, 2009
From: SCHENK, DALE B.; BUTTINI, MANUEL J.; CHILCOTE, TAMIE J.; GAMES, KATE DORA
To: ELAN PHARMACEUTICALS, INC.; REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 023074/0541 →
Assignment of Assignor's Interest Jan 11, 2012
From: ELAN PHARMACEUTICALS, INC.
To: CRIMAGUA LIMITED
Reel/Frame 027519/0009 →
Assignment of Assignor's Interest Jan 11, 2012
From: CRIMAGUA LIMITED
To: JANSSEN ALZHEIMER IMMUNOTHERAPY
Reel/Frame 027519/0144 →
Assignment of Assignor's Interest Jun 26, 2013
From: JANSSEN ALZHEIMER IMMUNOTHERAPY
To: NEOTOPE BIOSCIENCES LIMITED
Reel/Frame 030688/0711 →
Change of Name Aug 26, 2016
From: NEOTOPE BIOSCIENCES LIMITED
To: PROTHENA BIOSCIENCES LIMITED
Reel/Frame 039558/0335 →